首页 > 最新文献
paperpass

Pharmaceutical Communications最新文献

英文 中文
Formulation and Evaluation of Metronidazole Loaded Nanosponges for Topical Delivery 外用甲硝唑纳米海绵的制备及评价
Pub Date : 2022-12-31 DOI: 10.55627/pharma.001.001.0185
Rashid A Khan, Dr. Anum Saif, Humaira Naureen, Atif Sarwar, Muhammad Ali Shahbaz, Muhammad Nouman Arif
Formulations of metronidazole M1, M2, M3, M4, and M5 with the polymer ethyl cellulose and M1*, M2*, M3*, M4* and M5* with the polymer Eudragit RS100 at varying concentrations were prepared and characterized by Zeta sizer, SEM, DSC, FTIR and XRD. The gel was evaluated for its spreadability, skin irritancy, entrapment efficiency and drug release. Size in M5* was 292.2 nm with PDI of 1.00 and in M2, 371.8 nm with PDI of 0.809 was observed. The entrapment efficiency and production yield with M5* was observed to be 68.40 % and 66.9 % respectively. While the EE and PY with M2 were 66.70 % and 58 % respectively. FTIR did not reveal any incompatibility between the polymer and the drugs and by SEM results, the shape of nanosponges appeared to be spherical and porous. 10% of the drug was released from nanosponges in Ist hour and almost 70 % in 8 hours.
制备了甲硝唑M1、M2、M3、M4、M5与聚合物乙基纤维素和M1*、M2*、M3*、M4*、M5*与聚合物Eudragit RS100在不同浓度下的配方,并用Zeta浆料、SEM、DSC、FTIR和XRD对其进行了表征。对凝胶的涂抹性、皮肤刺激性、包封效率和药物释放进行了评价。M5*的尺寸为292.2 nm, PDI为1.00;M2的尺寸为371.8 nm, PDI为0.809。M5*的捕集效率和产量分别为68.40%和66.9%。M2的EE和PY分别为66.70%和58%。FTIR未发现聚合物与药物之间存在不相容性,SEM结果显示纳米海绵呈球形和多孔状。纳米海绵在1小时内释放10%的药物,在8小时内释放近70%的药物。
{"title":"Formulation and Evaluation of Metronidazole Loaded Nanosponges for Topical Delivery","authors":"Rashid A Khan, Dr. Anum Saif, Humaira Naureen, Atif Sarwar, Muhammad Ali Shahbaz, Muhammad Nouman Arif","doi":"10.55627/pharma.001.001.0185","DOIUrl":"https://doi.org/10.55627/pharma.001.001.0185","url":null,"abstract":"Formulations of metronidazole M1, M2, M3, M4, and M5 with the polymer ethyl cellulose and M1*, M2*, M3*, M4* and M5* with the polymer Eudragit RS100 at varying concentrations were prepared and characterized by Zeta sizer, SEM, DSC, FTIR and XRD. The gel was evaluated for its spreadability, skin irritancy, entrapment efficiency and drug release. Size in M5* was 292.2 nm with PDI of 1.00 and in M2, 371.8 nm with PDI of 0.809 was observed. The entrapment efficiency and production yield with M5* was observed to be 68.40 % and 66.9 % respectively. While the EE and PY with M2 were 66.70 % and 58 % respectively. FTIR did not reveal any incompatibility between the polymer and the drugs and by SEM results, the shape of nanosponges appeared to be spherical and porous. 10% of the drug was released from nanosponges in Ist hour and almost 70 % in 8 hours.","PeriodicalId":123783,"journal":{"name":"Pharmaceutical Communications","volume":"35 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120943024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-formulation Study of Tamoxifen and Excipients in Formulation of Nanoparticle Drug Delivery System 他莫昔芬及其辅料在纳米给药系统中的预处方研究
Pub Date : 2022-12-31 DOI: 10.55627/pharma.001.001.0197
Muzna Ali Khattak, Z. Iqbal, Sadia Pervez, Taleya Hidayatullah, Shazma Gohar, Tahir Ali Arbab
The inactive ingredients (excipients) are integral to the pharmaceutical drug delivery system. If not selected intelligently and added without a proper scientific approach can lead to the instability of the active pharmaceutical ingredient (API), low therapeutic outcome, or untoward effects.  In this investigation, pre-formulation studies were carried out to confirm that the excipients used in the preparation of the nanoparticles were compatible with tamoxifen. The high-performance liquid chromatography-ultra-violet assay, Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and thermogravimetric analysis (TGA) of the stored preparation showed that the nanoparticles were stable, indicating that the ingredients were not reactive and compatible with each other. The tamoxifen drug content was above 98%. Also, the FTIR spectrum of the optimized and physical mixture showed that the API retained its major (1357.89 cm-1, 1589.34 cm-1, 1739.79 cm-, 12870.08 cm-1, and 3402.43 cm-1) characteristic peaks. The XRD confirmed that the drug is very well dispersed in amorphous form with no extraneous peaks. The TGA isotherm indicated that the melting point of the optimized formulation was 400 oC which is significantly higher than the pure tamoxifen, which is 150 oC. the TGA results indicated that the formulation is heat stable.
非活性成分(赋形剂)是药物传递系统的组成部分。如果不明智地选择和添加而没有适当的科学方法,可能导致活性药物成分(API)的不稳定,低治疗效果或不良效果。在本研究中,进行了配方前研究,以确认纳米颗粒制备中使用的赋形剂与他莫昔芬相容。通过高效液相色谱-紫外分析、傅里叶变换红外光谱(FTIR)、x射线衍射(XRD)和热重分析(TGA)对所制备的纳米颗粒进行了表征,结果表明所制备的纳米颗粒具有较好的稳定性,表明所制备的纳米颗粒无反应性,且相互之间具有相容性。他莫昔芬含量在98%以上。优化后和物理混合后的FTIR光谱显示,原料药保留了其主要特征峰(1357.89 cm-1、1589.34 cm-1、1739.79 cm-1、12870.08 cm-1和3402.43 cm-1)。XRD证实药物以无定形分散,无多余峰。TGA等温线结果表明,优化配方的熔点为400℃,明显高于纯他莫昔芬的150℃。热重分析结果表明,该配方热稳定。
{"title":"Pre-formulation Study of Tamoxifen and Excipients in Formulation of Nanoparticle Drug Delivery System","authors":"Muzna Ali Khattak, Z. Iqbal, Sadia Pervez, Taleya Hidayatullah, Shazma Gohar, Tahir Ali Arbab","doi":"10.55627/pharma.001.001.0197","DOIUrl":"https://doi.org/10.55627/pharma.001.001.0197","url":null,"abstract":"The inactive ingredients (excipients) are integral to the pharmaceutical drug delivery system. If not selected intelligently and added without a proper scientific approach can lead to the instability of the active pharmaceutical ingredient (API), low therapeutic outcome, or untoward effects.  In this investigation, pre-formulation studies were carried out to confirm that the excipients used in the preparation of the nanoparticles were compatible with tamoxifen. The high-performance liquid chromatography-ultra-violet assay, Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and thermogravimetric analysis (TGA) of the stored preparation showed that the nanoparticles were stable, indicating that the ingredients were not reactive and compatible with each other. The tamoxifen drug content was above 98%. Also, the FTIR spectrum of the optimized and physical mixture showed that the API retained its major (1357.89 cm-1, 1589.34 cm-1, 1739.79 cm-, 12870.08 cm-1, and 3402.43 cm-1) characteristic peaks. The XRD confirmed that the drug is very well dispersed in amorphous form with no extraneous peaks. The TGA isotherm indicated that the melting point of the optimized formulation was 400 oC which is significantly higher than the pure tamoxifen, which is 150 oC. the TGA results indicated that the formulation is heat stable.","PeriodicalId":123783,"journal":{"name":"Pharmaceutical Communications","volume":"86 1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131371185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review on Transdermal Drug Delivery: Design, Evaluation and Approach towards Painless Drug Delivery System 经皮给药:无痛给药系统的设计、评价与研究进展
Pub Date : 2022-12-31 DOI: 10.55627/pharma.001.001.0196
Muhammad Shahid Latif, A. Nawaz, Muhammad Khursheed Alam Shah, A. Iqbal
Transdermal drug delivery systems were developed in order to overcome the difficulties associated with oral drug delivery. Through an adhesive patch affixed to the skin, transdermal patches deliver medications into the bloodstream. This treatment may benefit damaged areas of the body. Unlike oral, topical, intramuscular, and intravenous drug delivery methods, transdermal drug delivery enables controlled drug release into the body. Body heat is used to melt thin layers of medication embedded in the adhesive through the transdermal patch's porous membrane. As a barrier against foreign invaders, the skin serves as a protective layer. A medication with a molecular weight less than 500 Da can penetrate the stratum corneum through the outermost layer of the skin. An overview of transdermal patches is provided in this review article, including matrix patches, reservoir patches, membrane patches, micro reservoir patches, and patches that contain drugs in adhesive forms. These dosage forms have also been evaluated using various methods.
经皮给药系统的发展是为了克服口服给药的困难。通过贴在皮肤上的贴片,透皮贴片将药物输送到血液中。这种治疗可能对身体受损部位有益。与口服、局部、肌肉和静脉给药方法不同,经皮给药可以控制药物释放到体内。通过透皮贴片的多孔膜,体热被用来融化嵌入粘合剂中的薄层药物。作为抵御外来入侵者的屏障,皮肤起到了保护层的作用。分子量小于500da的药物可以通过皮肤的最外层穿透角质层。本文综述了透皮贴片的研究进展,包括基质贴片、储层贴片、膜贴片、微储层贴片和以黏附形式含有药物的贴片。这些剂型也用各种方法进行了评价。
{"title":"A Review on Transdermal Drug Delivery: Design, Evaluation and Approach towards Painless Drug Delivery System","authors":"Muhammad Shahid Latif, A. Nawaz, Muhammad Khursheed Alam Shah, A. Iqbal","doi":"10.55627/pharma.001.001.0196","DOIUrl":"https://doi.org/10.55627/pharma.001.001.0196","url":null,"abstract":"Transdermal drug delivery systems were developed in order to overcome the difficulties associated with oral drug delivery. Through an adhesive patch affixed to the skin, transdermal patches deliver medications into the bloodstream. This treatment may benefit damaged areas of the body. Unlike oral, topical, intramuscular, and intravenous drug delivery methods, transdermal drug delivery enables controlled drug release into the body. Body heat is used to melt thin layers of medication embedded in the adhesive through the transdermal patch's porous membrane. As a barrier against foreign invaders, the skin serves as a protective layer. A medication with a molecular weight less than 500 Da can penetrate the stratum corneum through the outermost layer of the skin. An overview of transdermal patches is provided in this review article, including matrix patches, reservoir patches, membrane patches, micro reservoir patches, and patches that contain drugs in adhesive forms. These dosage forms have also been evaluated using various methods.","PeriodicalId":123783,"journal":{"name":"Pharmaceutical Communications","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130789499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biological Applications of Magnetic Nanoparticles; A Review 磁性纳米颗粒的生物学应用研究回顾
Pub Date : 2022-12-31 DOI: 10.55627/pharma.001.001.0200
Shahana Khattak, Gul Rehman Elmi, Farah Azhar, Hina Ahsan, Kalsoom Saleem, Faryal Jahan
In nanotechnology field, iron oxide magnetic nanoparticles (IONPs) have gained much interest. The magnetic nanoparticles have been widely explored for applications due to ease of manufacturing and functionalization with polymers and other materials which makes them highly sensitive for many biological and biomedical applications. They transform electromagnetic energy into heat when exposed to magnetic field, and, hence, prove themselves as potent anti-cancer agent. The most advanced application of nanoscale materials towards human health is application as contrast agents in imaging modalities. MNPs proved safer as imaging contrast agents than conventional methods. MNPs have also been used in overcoming bacterial resistance and as anti-viral agent. They provide further evidences as emerging means in treatment and diagnosis of CVD and chronic inflammatory diseases like Rheumatoid arthritis. They also have employed in gene therapy to treat chronic diseases now a day.
在纳米技术领域,氧化铁磁性纳米颗粒(IONPs)受到了广泛的关注。磁性纳米颗粒由于易于制造和与聚合物和其他材料的功能化,使其对许多生物和生物医学应用具有高度敏感性,因此已被广泛探索应用。当暴露在磁场中时,它们将电磁能转化为热能,从而证明自己是有效的抗癌剂。纳米材料对人类健康最先进的应用是在成像模式中作为造影剂。MNPs作为成像造影剂被证明比传统方法更安全。MNPs也被用于克服细菌耐药性和抗病毒药物。它们为心血管疾病和风湿性关节炎等慢性炎症性疾病的治疗和诊断提供了进一步的证据。他们也在基因疗法中应用于慢性疾病的治疗。
{"title":"Biological Applications of Magnetic Nanoparticles; A Review","authors":"Shahana Khattak, Gul Rehman Elmi, Farah Azhar, Hina Ahsan, Kalsoom Saleem, Faryal Jahan","doi":"10.55627/pharma.001.001.0200","DOIUrl":"https://doi.org/10.55627/pharma.001.001.0200","url":null,"abstract":"In nanotechnology field, iron oxide magnetic nanoparticles (IONPs) have gained much interest. The magnetic nanoparticles have been widely explored for applications due to ease of manufacturing and functionalization with polymers and other materials which makes them highly sensitive for many biological and biomedical applications. They transform electromagnetic energy into heat when exposed to magnetic field, and, hence, prove themselves as potent anti-cancer agent. The most advanced application of nanoscale materials towards human health is application as contrast agents in imaging modalities. MNPs proved safer as imaging contrast agents than conventional methods. MNPs have also been used in overcoming bacterial resistance and as anti-viral agent. They provide further evidences as emerging means in treatment and diagnosis of CVD and chronic inflammatory diseases like Rheumatoid arthritis. They also have employed in gene therapy to treat chronic diseases now a day.","PeriodicalId":123783,"journal":{"name":"Pharmaceutical Communications","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128292201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Hydrotropic Phenomenon on Solubility Enhancement of Ebastine; Formulation and Characterization 嗜水现象对碱溶解度增强的影响配方与表征
Pub Date : 2022-12-31 DOI: 10.55627/pharma.001.001.0180
Anum Saif, Rashid Ali, Khan, S. Zaman, Muhammad Ali Shahbaz, Atif Sarwar, Muhammad Nouman Arif
Hydrotropes are the nontoxic small organic molecules that at certain concentrations result in solubility enhancement of poorly water-soluble compounds. In this study various hydrotropes including nicotinamide, sodium acetate and trisodium citrate were used at varying ratios to observe the effect on solubility enhancement of Ebastine. Various combinations of drug-hydrotrope complexes were prepared with each above mentioned hydrotropes using solvent evaporation technique. The resultant residues were subjected to various analytical and characterization techniques for verification of complexation and solubility enhancement. These techniques included Powder X-ray diffraction studies, FTIR and UV spectroscopy. Three different formulations were prepared using various hydrotrop-drug complexes and their stability studies along with in-vitro release were carried out using simulated environment in dissolution apparatus and then later UV spectrophotometric studies were conducted.Standard curve was constructed for UV Spectroscopic analysis and the UV analysis of %age drug release from final suspension dosage form revealed 67.56%, 55.04 % and 66.76 % for the complex containing drug-nicotinamide at ratio of 3:1, drug- sodium acetate at 2:2and drug-trisodium citrate at 2:2 respectively. This release profile clearly indicated the increment in water solubility of the said insoluble drug in the prepared suspension formulated from the drug-hydrotrope complex
亲水化合物是一种无毒的小有机分子,在一定浓度下可提高水溶性差的化合物的溶解度。本研究采用烟酰胺、乙酸钠和柠檬酸三钠等不同比例的水变性物,观察其对埃巴斯丁溶解度的增强作用。采用溶剂蒸发技术制备了不同的药物-亲水配合物组合。所得残留物进行了各种分析和表征技术,以验证络合和溶解度的增强。这些技术包括粉末x射线衍射研究,FTIR和UV光谱。采用不同的水合药物配合物制备了3种不同的制剂,并在溶出仪模拟环境下对其稳定性和体外释放度进行了研究,然后进行了紫外分光光度法的研究。建立标准曲线进行紫外光谱分析,最终混悬剂型的药物释放率为:药物与烟酰胺的比例为3:1,药物与乙酸钠的比例为2:2,药物与柠檬酸三钠的比例为2:2,其释放率分别为67.56%、55.04%和66.76%。该释放谱清楚地表明,所述不溶性药物在由药物-水络合物配制的制备悬浮液中的水溶性增加
{"title":"Effects of Hydrotropic Phenomenon on Solubility Enhancement of Ebastine; Formulation and Characterization","authors":"Anum Saif, Rashid Ali, Khan, S. Zaman, Muhammad Ali Shahbaz, Atif Sarwar, Muhammad Nouman Arif","doi":"10.55627/pharma.001.001.0180","DOIUrl":"https://doi.org/10.55627/pharma.001.001.0180","url":null,"abstract":"Hydrotropes are the nontoxic small organic molecules that at certain concentrations result in solubility enhancement of poorly water-soluble compounds. In this study various hydrotropes including nicotinamide, sodium acetate and trisodium citrate were used at varying ratios to observe the effect on solubility enhancement of Ebastine. Various combinations of drug-hydrotrope complexes were prepared with each above mentioned hydrotropes using solvent evaporation technique. The resultant residues were subjected to various analytical and characterization techniques for verification of complexation and solubility enhancement. These techniques included Powder X-ray diffraction studies, FTIR and UV spectroscopy. Three different formulations were prepared using various hydrotrop-drug complexes and their stability studies along with in-vitro release were carried out using simulated environment in dissolution apparatus and then later UV spectrophotometric studies were conducted.Standard curve was constructed for UV Spectroscopic analysis and the UV analysis of %age drug release from final suspension dosage form revealed 67.56%, 55.04 % and 66.76 % for the complex containing drug-nicotinamide at ratio of 3:1, drug- sodium acetate at 2:2and drug-trisodium citrate at 2:2 respectively. This release profile clearly indicated the increment in water solubility of the said insoluble drug in the prepared suspension formulated from the drug-hydrotrope complex","PeriodicalId":123783,"journal":{"name":"Pharmaceutical Communications","volume":"63 39","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114005596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Welcome to Pharmaceutical Communications 欢迎来到药学通讯
Pub Date : 2022-12-31 DOI: 10.55627/pharma.001.001.0203
F. Nasir
Welcome to the inaugural issue of Pharmaceutical Communications-a biannual, open access, and peer-reviewed journal aiming to publish high-quality research articles in the field of basic & advanced pharmaceutics and pharmaceutical technology. Pharmaceutical Communications is a biannual, peer-reviewed journal published online and in print that primarily publishes research articles and reviews that focus on basic and advanced pharmaceutics. The journal accepts manuscripts related to but not limited to, the processing of pharmaceuticals, such as crystallization, lyophilization, chemical stability of drugs, pharmacokinetics, biopharmaceutics, pro-drug developments, metabolic disposition of bioactive agents, dosage form design, pharmaceutical technology, targeted drug delivery. Other topics include pharmaceutical marketing, pharmaceutical promotion, patient-provider communication, healthcare communication, patient safety, and innovations in the pharmaceutical industry.Pharmaceutical Communications primarily accepts original research articles and reviews. However, invited editorial summaries and letters to the editor are also occasionally published.The journal provides a platform for scientists, practitioners, and healthcare professionals to share their knowledge and experiences in the field of pharmaceutics. The journal also serves as a forum for discussing and debating current issues and trends in the pharmaceutical industry. The journal welcomes submissions from academics, practitioners, and industry professionals who wish to share their research and perspectives on topics related to pharmaceutics.In the last two decades, rapid technological advances have enabled researchers to investigate arcane technological phenomena and ask more profound questions. Several pharmaceutical processes involved in the manufacturing of various dosage forms are being unraveled at a rapid pace, high resolution, and with unprecedented details. Authors carrying out investigations leveraging these technologies dealing with the composition, formulation, preparation, or manufacturing and quality control of extemporaneously compounded or commercially manufactured drugs are encouraged to submit their findings to Pharmaceutical Communications.The purpose of this journal is to provide a platform to the scientific fraternity, especially regional and national academics, where they could get their studies published after a rapid, transparent, and high-quality peer review. All the articles published in Pharmaceutical Communications will be freely available to readers immediately after publication. The open-access policy of our journal is likely to increase the readership of articles and enhance their visibility and citation potential. The journal also welcomes submissions from authors from any country. Therefore, I invite you to submit your work to Pharmaceutical Communications. We look forward to receiving your submissions!Professor Dr. Fazli NasirEditor-In-ChiefRehabilitatio
欢迎来到《药学通讯》的创刊号,这是一本两年一次、开放获取、同行评审的期刊,旨在发表基础和先进制药和制药技术领域的高质量研究文章。《药学通讯》是一本半年度同行评议的在线和印刷期刊,主要发表研究文章和评论,重点关注基础和高级制药。本刊接受与但不限于药物加工相关的稿件,如结晶、冻干、药物的化学稳定性、药代动力学、生物制药、前药物开发、生物活性剂的代谢处置、剂型设计、制药技术、靶向给药。其他主题包括药品营销、药品促销、医患沟通、医疗保健沟通、患者安全以及制药行业的创新。《药学通讯》主要接受原创研究文章和评论。但是,偶尔也会发表特邀的编辑摘要和给编辑的信。该杂志为科学家、从业者和医疗保健专业人员提供了一个分享他们在制药领域的知识和经验的平台。该杂志还作为讨论和辩论制药行业当前问题和趋势的论坛。该期刊欢迎来自学术界、实践者和行业专业人士的投稿,他们希望分享他们对制药相关主题的研究和观点。在过去的二十年里,快速的技术进步使研究人员能够研究神秘的技术现象并提出更深刻的问题。制造各种剂型所涉及的几种制药工艺正在以快速、高分辨率和前所未有的细节得到揭示。鼓励作者利用这些技术进行调查,处理临时合成或商业生产药物的组成、配方、制备或制造和质量控制,将他们的发现提交给《药学通讯》。本刊的目的是为科学界,特别是地区和国家的学者提供一个平台,在那里他们可以在快速、透明和高质量的同行评议后发表他们的研究。所有发表在《药学通讯》上的文章将在发表后立即免费提供给读者。我们期刊的开放获取政策可能会增加文章的读者群,提高文章的知名度和被引用的潜力。该杂志也欢迎来自任何国家的作者投稿。因此,我邀请您将您的工作提交给《药学通讯》。我们期待收到您的投稿!Fazli nasir教授,康复通讯主编
{"title":"Welcome to Pharmaceutical Communications","authors":"F. Nasir","doi":"10.55627/pharma.001.001.0203","DOIUrl":"https://doi.org/10.55627/pharma.001.001.0203","url":null,"abstract":"Welcome to the inaugural issue of Pharmaceutical Communications-a biannual, open access, and peer-reviewed journal aiming to publish high-quality research articles in the field of basic & advanced pharmaceutics and pharmaceutical technology. Pharmaceutical Communications is a biannual, peer-reviewed journal published online and in print that primarily publishes research articles and reviews that focus on basic and advanced pharmaceutics. The journal accepts manuscripts related to but not limited to, the processing of pharmaceuticals, such as crystallization, lyophilization, chemical stability of drugs, pharmacokinetics, biopharmaceutics, pro-drug developments, metabolic disposition of bioactive agents, dosage form design, pharmaceutical technology, targeted drug delivery. Other topics include pharmaceutical marketing, pharmaceutical promotion, patient-provider communication, healthcare communication, patient safety, and innovations in the pharmaceutical industry.\u0000Pharmaceutical Communications primarily accepts original research articles and reviews. However, invited editorial summaries and letters to the editor are also occasionally published.\u0000The journal provides a platform for scientists, practitioners, and healthcare professionals to share their knowledge and experiences in the field of pharmaceutics. The journal also serves as a forum for discussing and debating current issues and trends in the pharmaceutical industry. The journal welcomes submissions from academics, practitioners, and industry professionals who wish to share their research and perspectives on topics related to pharmaceutics.\u0000In the last two decades, rapid technological advances have enabled researchers to investigate arcane technological phenomena and ask more profound questions. Several pharmaceutical processes involved in the manufacturing of various dosage forms are being unraveled at a rapid pace, high resolution, and with unprecedented details. Authors carrying out investigations leveraging these technologies dealing with the composition, formulation, preparation, or manufacturing and quality control of extemporaneously compounded or commercially manufactured drugs are encouraged to submit their findings to Pharmaceutical Communications.\u0000The purpose of this journal is to provide a platform to the scientific fraternity, especially regional and national academics, where they could get their studies published after a rapid, transparent, and high-quality peer review. All the articles published in Pharmaceutical Communications will be freely available to readers immediately after publication. The open-access policy of our journal is likely to increase the readership of articles and enhance their visibility and citation potential. The journal also welcomes submissions from authors from any country. Therefore, I invite you to submit your work to Pharmaceutical Communications. We look forward to receiving your submissions!\u0000Professor Dr. Fazli Nasir\u0000Editor-In-Chief\u0000Rehabilitatio","PeriodicalId":123783,"journal":{"name":"Pharmaceutical Communications","volume":"64 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123482359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pharmaceutical Communications
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
mjeditor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1